LOADING
Comparing Mastercard Inc (MA) and Pfizer Inc (PFE) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MA | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $481.8B | $158.5B |
| P/E Ratio | 30.3 | 37.1 |
| Forward P/E | 24.2 | 9.7 |
| PEG Ratio | 1.46 | 12.89 |
| EPS | $18.15 | $0.75 |
| Revenue Growth (YoY) | 14.1% | 2.6% |
| Profit Margin | 46.3% | 6.8% |
| Return on Equity | 241.2% | 5.0% |
| Dividend Yield | 0.61% | 6.12% |
| Beta | 0.73 | 0.30 |
| 52-Week High | $601.23 | $29.21 |
| 52-Week Low | $463.74 | $22.57 |
| Volume | -- | -- |
Mastercard Inc is the larger company by market capitalization. Mastercard Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Mastercard Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.